Abstract
Snake venoms contain a large variety of proteins and peptides that affect the hemostasis and thrombosis. Numerous antithrombotic peptides have been found in snake venom. However, few studies have been performed on the proteolysis of snake venom for obtaining bioactive peptides. In this study, the Agkistrodon acutus venom was hydrolyzed using four commercial proteases (pepsin, papain, neutrase, and alcalase) and the hydrolysate was tested for antiplatelet aggregation activity. The pepsin hydrolysate, exhibiting the highest activity, was further purified by gel filtration and reversed-phase high performance liquid chromatography. A novel antithrombotic peptide SP-14 was obtained, and its sequence was identified as SHIHGDYSSPSGAP using tandem electrospray mass spectrometry. SP-14 inhibited U46619-induced rabbit platelet aggregation in a dose-dependent manner. It reduced the mortality of mice in acute pulmonary thrombosis model and decreased thrombus weight in rat arteriovenous shunt model, while with lower bleeding risk than aspirin. Therefore, SP-14 may be beneficial for new antithrombotic drug design and development.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Peptide Research and Therapeutics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.